Neuro-Oncology Reviews

Volume 27 Number 1
10 January 2025

Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 1, 10 January

Agnihotri TG, Dahifale A, Gomte SS, Rout B, Peddinti V, Jain A.
Nanosystems at Nexus: Navigating Nose-to-Brain Delivery for Glioblastoma Treatment.
Mol Pharm. 2025 Jan 2. doi: 10.1021/acs.molpharmaceut.4c00703. PMID: 39746097. Review˰ ˍ

Mandelberg N, Hodges TR, Wang TJC, McGranahan T, Olson JJ, Orringer DA.
Congress of Neurological Surgeons systematic review and evidence based guideline on neuropathology for WHO grade II diffuse glioma: update.
J Neurooncol. 2025 Jan 2. doi: 10.1007/s11060-024-04898-7. PMID: 39747718. Guidelines˰ ˍ

Barić H, Komljenović S, Garcia SG, Niemelä M.
Skull base meningiomas: A bibliometric analysis and comprehensive overview of clinical reports.
Neurochirurgie. 2025 Jan 3;71(2):101632. doi: 10.1016/j.neuchi.2025.101632. PMID: 39756613. Bibliometric analysis˰ ˍ

Dorfner FJ, Patel JB, Kalpathy-Cramer J, Gerstner ER, Bridge CP.
A review of deep learning for brain tumor analysis in MRI.
NPJ Precis Oncol. 2025 Jan 3;9(1):2. doi: 10.1038/s41698-024-00789-2. PMID: 39753730. Review. ˍ

*Sangubotla R, Gubbiyappa KS, Devarapogu R, Kim J.
Modern insights of nanotheranostics in the glioblastoma: An updated review.
Biochim Biophys Acta Mol Basis Dis. 2025 Jan 3:167653. doi: 10.1016/j.bbadis.2024.167653. PMID: 39756713. Review˰ ˍ

Sharma E, Sahin OK, Łajczak P, Rajab N, Ahmed AR, Silva YP, Bakhsh A, Chatterjee A, Raake M, Fagundes W.
Synergistic effects of laser interstitial thermal therapy (LITT) and immunotherapy for brain tumor recurrence: A systematic review and meta-analysis.
Neurochirurgie. 2025 Jan 3;71(2):101629. doi: 10.1016/j.neuchi.2025.101629. PMID: 39756615 Review; Meta-Analysis˰ ˍ

Westphal M, Drexler R, Maire C, Ricklefs F, Lamszus K.
Cancer neuroscience and glioma: clinical implications.
Acta Neurochir (Wien). 2025 Jan 3;167(1):2. doi: 10.1007/s00701-024-06406-2. PMID: 39752006. Review. ˍ

Bakes E, Cheng R, Mañucat-Tan N, Ramaswamy V, Hansford JR.
Advances in molecular prognostication and treatments in ependymoma.
J Neurooncol. 2025 Jan 6. doi: 10.1007/s11060-024-04923-9. PMID: 39757304. Review˰ ˍ

Cheng J, Guo C.
Primary pulmonary meningioma: a case report and literature review.
J Cardiothorac Surg. 2025 Jan 7;20(1):44. doi: 10.1186/s13019-024-03259-9. PMID: 39773541. Case report; Review. ˍ

Mokarram N, Case A, Hossainy NN, Lyon JG, MacDonald TJ, Bellamkonda R.
Device-assisted strategies for drug delivery across the blood-brain barrier to treat glioblastoma.
Commun Mater. 2025 Jan 7;6(1):5. doi: 10.1038/s43246-024-00721-y. PMID: 39790893. Review. ˍ

Sadat Razavi Z, Sina Alizadeh S, Sadat Razavi F, Souri M, Soltani M.
Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration.
Int J Pharm. 2025 Jan 7;670:125186. doi: 10.1016/j.ijpharm.2025.125186. PMID: 39788400. Review. ˍ

Verger A, Tolboom N, Cicone F, Chang SM, Furtner J, Galldiks N, Gempt J, Guedj E, Huang RY, Johnson DR, Law I, Le Rhun E, Short SC, Bent MJVD, Weehaeghe DV, Vogelbaum MA, Wen PY, Albert NL, Preusser M.
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0.
Eur J Nucl Med Mol Imaging. 2025 Jan 7. doi: 10.1007/s00259-024-07038-5. PMID: 39762634. Guidelines. ˍ

de Melo SM, Elias Nunes da Silva ME, Torloni MR, Riera R, De Cicco K, Latorraca CO, Pinto ACPN.
Anti-PD-1 and anti-PD-L1 antibodies for glioma.
Cochrane Database Syst Rev. 2025 Jan 8;1(1):CD012532. doi: 10.1002/14651858.CD012532.pub2. PMID: 39777725. Meta-analysis˰ ˍ

Kumar D, Kanchan R, Chaturvedi NK.
Targeting protein synthesis pathways in MYC-amplified medulloblastoma.
Discov Oncol. 2025 Jan 8;16(1):23. doi: 10.1007/s12672-025-01761-7. PMID: 39779613. Review. ˍ

Vong CK, Wang A, Dragunow M, Park TI, Shim V.
Brain tumour histopathology through the lens of deep learning: A systematic review.
Comput Biol Med. 2025 Jan 8;186:109642. doi: 10.1016/j.compbiomed.2024.109642. PMID: 39787663. Review. ˍ

Whittle JR, Kriel J, Fatunla OE, Lu T, Moffet JJD, Spiteri M, Best SA, Freytag S.
Spatial omics shed light on the tumour organisation of glioblastoma.
Semin Cell Dev Biol. 2025 Jan 8;167:1-9. doi: 10.1016/j.semcdb.2024.12.006. PMID: 39787997. Review. ˍ

Duffau H.
Neuroplasticity in Diffuse Low-grade Gliomas: Backward Modelling of Brain-tumor Interactions Prior to Diagnosis is Needed to Better Predict Recovery after Treatment.
Curr Neurol Neurosci Rep. 2025 Jan 9;25(1):15. doi: 10.1007/s11910-024-01402-6. PMID: 39786618. Review˰ ˍ

Khalili BF, Walbert T, Horbinski C, Dixit K, Gururangan K, Thio H, Tate MC, Stupp R, Lukas RV, Templer JW.
Levetiracetam and valproic acid in glioma: antiseizure and potential antineoplastic effects.
Future Oncol. 2025 Jan 9:1-9. doi: 10.1080/14796694.2025.2450215. PMID: 39786974. Review˰ ˍ

Wach J, Vychopen M, Basaran AE, Tatagiba M, Goldbrunner R, Güresir E.
Overall survival and progression-free survival in pediatric meningiomas: a systematic review and individual patient-level meta-analysis.
J Neurooncol. 2025 Jan 9. doi: 10.1007/s11060-024-04917-7. PMID: 39779595. Review; Meta-analysis. ˍ

Yalamandala BN, Huynh TMH, Lien HW, Pan WC, Iao HM, Moorthy T, Chang YH, Hu SH.
Advancing brain immunotherapy through functional nanomaterials.
Drug Deliv Transl Res. 2025 Jan 9. doi: 10.1007/s13346-024-01778-5. PMID: 39789307. Review. ˍ